Application of Dual-tracer Positron Emission Tomography in the Pre-operative Diagnosis of Liver Masses
-
摘要:
目的 观察两种正电子发射计算机断层显像(positron emission tomography, PET)示踪剂对肝脏占位的诊断价值。 方法 选取本院2004年10月至2010年8月经常规检查无法定性的肝脏占位患者40例, 所有患者均接受18F-去氧葡萄糖(18F-fluorodeoxyglucose, 18F-FDG)-PET和11C-乙酸盐(11C-Acetate)-PET检查。 结果 40例肝脏占位患者经病理证实恶性病变33例, 癌前病变2例, 良性病变5例。双示踪剂PET检查诊断恶性病变34例, 敏感性为97.1%, 阳性预测值为91.9%;18F-FDG PET诊断恶性病变20例, 敏感性为57.1%;11C-Acetate PET诊断恶性病变29例, 敏感性为82.9%。对于不典型增生、高分化及中高分化的肝脏恶性肿瘤, 11C-Acetate的敏感性为100%, 显著高于18F-FDG的敏感性28.6%(P < 0.01);对于低分化、中低分化的肝脏恶性肿瘤, 18F-FDG的敏感性稍高, 但两者差异无统计学意义。 结论 两种PET示踪剂联合应用能提高肝脏占位的术前诊断率, 且有可能提示肿瘤的分化程度, 对于手术的选择有一定指导意义。 Abstract:Objective To evaluate the value of the dual-tracer positron emission tomography(PET)in the pre-operative diagnosis of liver masses. Methods Totally 40 patients whose liver masses could not be positioned by routine examination were enrolled in this study from October 2004 to August 2010.All patients received PET examination using 18F-fluorodeoxyglucose(18F-FDG)and 11C-Acetate as tracer. Results Of these 40 patients, the masses were pathologically confirmed to be malignant in 33 patients, precancerous changes in 2 patients, and benign in 5 patients.On the contrary, dual-tracer PET found malignant lesions in 34 patients, with a sensitivity of 97.1% and a positive predictive value of 91.9%.18F-FDG PET identified 20 malignant masses(57.1%)and 11C-Acetate PET identified 29(82.9%).For atypical hyperplasia, well differentiated lesions, and moderately well-differentiated lesions, the sensitivity of 11C-acetate(100%)was significantly higher than 18F-FDG(28.6%)(P < 0.01).However, for poorly differentiated lesions and moderately poor-differentiated lesions, the sensitivity of 18F-FDG was a bit higher but without statistical significance. Conclusion The combined application of these two tracers in PET can increase the diagnostic accuracy for liver masses preoperatively and may indicate the differentiation levels of tumors, and thus provides useful information for surgical decision-making. -
Key words:
- liver mass /
- positron emission tomography /
- 11C-Acetate /
- 18F-fluorodeoxyglucose /
- diagnosis
-
表 1 肝脏占位患者正电子发射计算机断层显像结果
表 2 恶性肝脏病变和癌前病变大小与正电子发射计算机断层显像结果
表 3 肝脏占位病理分化程度和正电子发射计算机断层显像结果
-
[1] Shariff MI, Cox IJ, Gomaa AI, et al.Hepato cellular carcinoma:current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics[J]. Expert Rev Gastroenterol Hepatol, 2009, 3:353-367. doi: 10.1586/egh.09.35 [2] Gambhir SS, Czernin J, Schwimmer J, et al.Atabulated summary of the FDG PET literature[J]. J Nucl Med, 2001, 42:1S-93S. http://www.ncbi.nlm.nih.gov/pubmed/11884507 [3] Fencl P, Belohlavek O, Skopalova M, et al.Prognostic and diagnostic accuracy of [18F] FDG-PET/CT in 190 patients with carcinoma of unknown primary[J]. Eur J Nucl Med Mol Imaging, 2007, 34:1783-1792. doi: 10.1007/s00259-007-0456-8 [4] Ho CL, Yu SC, Yueng DW.11C-Acetate PET imaging in hepatocellular carcinoma and other livermasses[J]. J Nucl Med, 2003, 44:213-221. http://so.med.wanfangdata.com.cn/ViewHTML/PeriodicalPaper_JJ0210079592.aspx [5] Delbeke D, Pinson CW.11C-Acetate:a new tracer for the evaluation of hepatocellular carcinoma[J]. J Nucl Med, 2003, 44:222-223. http://www.ncbi.nlm.nih.gov/pubmed/12571213 [6] Lin WY, Tsai SC, Hung GU.Value of delayed 18F-FDGPET imaging in the detection of hepatocellular carcinoma [J]. Nucl Med Commun, 2005, 26:315-321. doi: 10.1097/00006231-200504000-00003 [7] Iwata Y, Shiomi S, Sasaki N, et al.Clinical use fulness of positron emission tomography with fluorine-18-fluorodeoxyg lucose in the diagnosis of liver tumors[J]. Ann Nucl Med, 2000, 14:121-126. doi: 10.1007/BF02988591 [8] Khan MA, Combs CS, Brunt EM, et al.Positron emission tomography scanning in the evaluation of hepatocellular carcinoma[J]. J Hepatol, 2000, 32:792-797. http://europepmc.org/abstract/MED/10845666 [9] Torizuka T, Tamaki N, Inokuma T, et al.In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET[J]. J Nucl Med, 1995, 36:1811-1817. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=932122288fefac552ce2ce560041b6bd [10] Oyama N, Akino H, Kanamaru H, et al.11C-Acetate PET imaging of prostate cancer[J]. J Nucl Med, 2002, 43:181-186. http://europepmc.org/abstract/MED/11850482 [11] Yoshimoto M, Waki A, Yonekura Y, et al.Characterization of acetate metabolism in tumor cells in relation to cell proliferation:acetate metabolism in tumor cells[J]. Nucl Med Biol, 2001, 28:117-122. doi: 10.1016/S0969-8051(00)00195-5 [12] Ho CL, Chen S, Yeung DW, et al.Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma [J]. J Nucl Med, 2007, 48:902-909. doi: 10.2967/jnumed.106.036673 [13] Park JW, Kim JH, Kim SK, et al.A prospective evaluation of 18F-FDG and 11C-Acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma[J]. J Nucl Med, 2008, 49:1912-1921. doi: 10.2967/jnumed.108.055087 [14] 霍力, 周前, 党永红, 等.11C-Acetate与18FDGPET联合显像在肝脏肿瘤诊断中的作用[J].中国肿瘤, 2007, 16:184-186. http://d.wanfangdata.com.cn/Periodical/zgzl200703011 [15] 桑新亭, 杜顺达, 毛一雷, 等.两种正电子发射型计算机断层扫描显像在性质不明的肝脏占位诊断中的意义[J].中华医学杂志, 2007, 87:3122-3124. http://d.wanfangdata.com.cn/Periodical/zhyx200744008
计量
- 文章访问数: 189
- HTML全文浏览量: 73
- PDF下载量: 9
- 被引次数: 0